Peritoneal absorption of moxalactam.
We evaluated the rate and extent of the systemic absorption of moxalactam given intraperitoneally to patients with peritonitis and end-stage renal disease who were being maintained on continuous ambulatory peritoneal dialysis. Moxalactam was administered at a concentration of 200 mg per 2-liter dial...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1983
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC185101/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6625555/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.24.1.39 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|